Evonik Evonik

X

List of Japan Drug Master File (JDMF) for Nafamostat Active Pharmaceutical Ingredient submitted to the Review Authority in Japan (PMDA) and listed on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Flag Japan
Digital Content Digital Content
URL Supplier Web Content
226MF10002
1-15-1 Kyobashi, Chuo-ku, Tokyo
2014-01-08
2014-01-08
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
220MF10222
3-2-8 Nihonbashi Honmachi, Chuo-ku,...
2021-02-24
2008-11-04
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
218MF10299
3-2-8 Nihonbashi Honmachi, Chuo-ku,...
2006-11-06
2006-02-28
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
220MF10201
4-15-19 Hibarigaoka, Zama City, Kan...
2008-09-19
2008-09-19
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
223MF10091
4-15-19 Hibarigaoka, Zama City, Kan...
2011-06-29
2011-06-29
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
220MF10115
129 Suidocho, Aoi Ward, Shizuoka Ci...
2008-04-21
2008-04-21
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
217MF11135
7-6 Nihonbashi Odenmacho, Chuo-ku, ...
2006-04-27
2005-12-05
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 81525-10-2 / Nafamostat API manufacturers, exporters & distributors?

Nafamostat manufacturers, exporters & distributors 1

72

PharmaCompass offers a list of Nafamostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nafamostat manufacturer or Nafamostat supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nafamostat manufacturer or Nafamostat supplier.

PharmaCompass also assists you with knowing the Nafamostat API Price utilized in the formulation of products. Nafamostat API Price is not always fixed or binding as the Nafamostat Price is obtained through a variety of data sources. The Nafamostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Nafamostat

Synonyms

81525-10-2, Nafamostat [inn], Nafamstat, (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate, Chembl273264, Y25lq0h97d

Cas Number

81525-10-2

Unique Ingredient Identifier (UNII)

Y25LQ0H97D

About Nafamostat

Nafamostat is a broad-spectrum, synthetic serine protease inhibitor, with anticoagulant, anti-inflammatory, mucus clearing, and potential antiviral activities. Upon administration, nafamostat inhibits the activities of a variety of proteases, including thrombin, plasmin, kallikrein, trypsin, and Cl esterase in the complement system, and factors VIIa, Xa, and XIIa in the coagulation system. Although the mechanism of action of nafamostat is not fully understood, trypsinogen activation in the pancreas is known to be a trigger reaction in the development of pancreatitis. Nafamostat blocks the activation of trypsinogen to trypsin and the inflammatory cascade that follows. Nafamostat may also decrease epithelial sodium channel (ENaC) activity and increase mucus clearance in the airways. ENaC activity is increased in cystic fibrosis. In addition, nafamostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.

Nafamostat Manufacturers

A Nafamostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nafamostat, including repackagers and relabelers. The FDA regulates Nafamostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nafamostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nafamostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Nafamostat Suppliers

A Nafamostat supplier is an individual or a company that provides Nafamostat active pharmaceutical ingredient (API) or Nafamostat finished formulations upon request. The Nafamostat suppliers may include Nafamostat API manufacturers, exporters, distributors and traders.

click here to find a list of Nafamostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Nafamostat JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Nafamostat Drug Master File in Japan (Nafamostat JDMF) empowers Nafamostat API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Nafamostat JDMF during the approval evaluation for pharmaceutical products. At the time of Nafamostat JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Nafamostat suppliers with JDMF on PharmaCompass.

Nafamostat Manufacturers | Traders | Suppliers

Nafamostat Manufacturers, Traders, Suppliers 1
26

We have 5 companies offering Nafamostat

Get in contact with the supplier of your choice:

  1. Ajinomoto Company
  2. Kanto Chemical
  3. Katsura Chemical
  4. Nippi
  5. Permachem Asia, Ltd
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY